期刊文献+

早期实施血液灌流治疗重症胰腺炎疗效观察 被引量:13

Observation of Therapeutic Effects of Early Hemoperfusion on Patients with Severe Acute Pancreatitis
下载PDF
导出
摘要 目的探讨早期血液灌流术对重症胰腺炎患者的治疗作用。方法重症胰腺炎患者12例,首先给予常规内科治疗,在循环相对稳定后即早期给予血液灌流,每次2h,根据病情重复3~5次。结果12例重症胰腺炎患者最多经5次血液灌流后病情均明显稳定。全部病例经内科治疗后均痊愈出院。结论早期使用血液灌流治疗重症胰腺炎能够有效缓解临床症状,改善内环境及微循环稳定,降低死亡率、改善预后。值得在临床中推广使用。 Objective To investigate the therapeutic effects of early hemoperfusion on patients with severe acute pancreatitis(SAP). Methods 12 patients with SAP were first given conventional treatment, then followed by hemoperfusion as soon as the circulation became steady, 2 hours each time, 3-5 times depending on patient's condition. Result 12 patients's condition was significantly stable after hemoperfusion, 5 times at most. All the patients recovered and were discharged after successful treatment. Conclusion For the SAP, early hemoperfusion can efficiently improve the clinical symptoms, maintain the internal milieu and microcirculation, decrease the mortality, and it is worth clinical application.
出处 《实用临床医药杂志》 CAS 2007年第3期65-67,共3页 Journal of Clinical Medicine in Practice
基金 国家自自然科学基金资助项目(HSFC30371587)
关键词 血液灌流 重症胰腺炎 炎性介质 hemofusion severe acnte pancreatitis inflammatory medinm
  • 相关文献

参考文献9

  • 1Norman J.The role of cytokines in the pathogenesis of acute pancreatitis[J].AM J Surg,1998,175:76. 被引量:1
  • 2姚榛祥.重症急性胰腺炎现代治疗的认识.中华肝胆外科杂志,1995,5:56-56. 被引量:2
  • 3Gukovskaya A S,Gukovsky L,Zaninovic V,et al.Pancreatic acinar cells prouduce,release and respond to tumor necrosis factor[J].J clin Invest,1997,100:76. 被引量:1
  • 4Kodama M,Tani T,Maekawa K.Endotoxin eliminating rherapy in patients with severe sespisdirect hemoperfusion using polymyxin B immobilized fiber colmn[J].Am J Surg,1994,167(4):412. 被引量:1
  • 5黎磊石.连续性肾脏替代治疗与重症疾病的救治[J].肾脏病与透析肾移植杂志,1999,8(3):205-206. 被引量:131
  • 6Silverter W.Mediator removal with CRRT:complement and cytokines[J].Am J Kidney Dis,1997,30(5 supp14):38.Siberth H G,Kierdorf H P.Is cytokine removal by continuous hemofiltration feasible-Kindey Int,1999,72(suppl):79. 被引量:1
  • 7王毅军,徐东波,杜斌,杜智.NK-107树脂血液灌流治疗重症急性胰腺炎犬的实验研究[J].生物医学工程与临床,2002,6(2):72-75. 被引量:25
  • 8Kodama M,Aoki H,Tani T.Hemoperfusion using a polymyxin Bimmobilized fiber column for the removal of endotoxin,In:Lecin J,Alving C R,Munford R S,eds.Bacterial endotoxin:recognition and effector meehanisms,Amsterdam:The Netherlands Elsevier Scince Publishers,1993.389. 被引量:1
  • 9李力,陶新朝,李燕玲,张萍,张广子,杨歌明.吸附树脂对低密度脂蛋白(LDL)吸附性能的研究[J].武警医学院学报,2001,10(4):288-290. 被引量:12

二级参考文献10

  • 1Hirota M, Nozawa F, Okabe A, et al. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis[J]. Pancreas,2000,21(2):141-146 被引量:1
  • 2Brady M, Christmas S, Sutton R, et al. Cytokines and acute pancreatitis[J]. Baillieres Best Pract Res Clin Gastroenterol,1999,13(2):265-289 被引量:1
  • 3Powell JJ, Fearon KC, Siriwardena AK, et al. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis[J]. Surgery, 2001,129(5):633-640 被引量:1
  • 4Lipsett PA. Serum cytokines, proteins, and receptors in acute pancreatitis:Mediators,markers, or more of the same?[J] Crit Care Med, 2001,29(8):1642-1644 被引量:1
  • 5Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis[J]. Curr Opin Investig Drugs,2001,2(4):496-501 被引量:1
  • 6Shimada M, Andoh A, Hata K, et al. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators[J]. J Immunol,2002,168(2):861-868 被引量:1
  • 7Kamijo Y, Wakabayashi Y, Shirasaki K, et al. Continuous hemofiltration removes circulatory cytokine and improves multiple organ dysfunction syndrome following severe acute pancreatitis--a case report[J]. Nippon Shokakibyo Gakkai Zasshi,1995,92(6):1013 被引量:1
  • 8Bosch T. State of the art of lipid apheresis [J]. Artif Organs, 1996, 20 (4): 292-295 被引量:1
  • 9Bosch T, Schmidt B, Kleophas W, et al. LDL hemoperfusion - a new procedure for LDL apheresis: first clinical application of an LDL adsorder compatibal with human whole blood[J]. ArtifOrgans, 1997, 21 (9): 977-982. 被引量:1
  • 10Bosch T, Lennertz A, Kordes B, et al. Low density lipoperfusion by sirecy adsorption of lipoproteins from whole blood(DALI apheresis): clinical experience from a single center[J]. Ther Apher, 1999, 3 (3): 209-13. 被引量:1

共引文献163

同被引文献104

引证文献13

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部